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other indications 15.23% (n= 1320). Comparing prescribing across the six sites, car-
diovascular indications remained the most common and showed the lowest rela-
tive standard deviation across the six sites (x ̅= 41.38%, SD = ±6.68, RSD = 16.14%). 
Respiratory tract (x   ̅= 9.56%, SD= ±6.24, RSD= 65.27%) and musculoskeletal indica-
tions (x ̅= 3.78%, SD= ±2.35, RSD= 62.17%) showed the greatest variation in prescrib-
ing across the six sites. ConClusions: Prescribing for cardiovascular indications 
accounted for the highest percentage of medications at each individual site. It was 
also the most consistent, showing the lowest variation in percentages across all 
six sites. This supports the fact that cardiovascular criteria make up the largest 
section of the STOPP/START criteria. Prescribing for respiratory tract and muscu-
loskeletal indications showed the highest level of variation across the six sites. 
This variation may be indicative of over-prescribing in some sites and under-
prescribing in others.
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objeCtives: The prevalence of pneumonia, meningitis and septicemia cases 
recorded among 50+ Hungarian population has been growing. One of the main 
reasons of the year by year higher occurrences is the ever ageing population, 
where the incidence is higher generating significant incremental resource utiliza-
tion. Methods: The study determines whether the probability of morbidity over 
50+ has changed (using general linear model - GLM) and the direct health care cost 
of the three mentioned diseases based on the National Health Insurance Fund 
database. Cases and direct healthcare cost of inpatient, outpatient care, diagnos-
tics and medication were defined with an analysis of the Hungarian population. 
The study that covers the 2005-2013 timeframe in 5 year age-groups does not 
calculates indirect burden. Results: The research shows that the age increases 
the probability of disease. Between the age groups 40-49 and 50-54 the probability 
of disease increased by 26% (from GLM model, which is significant) and growing 
in each age-group. The prevalence of analyzed diseases among 50+ Hungarian 
population has increased by 10% between 2005 and 2013 resulting an incremental 
2.34 billion HUF extra direct health care cost expenditure. Approximately 77% 
of this extra amount was used by the 65+ population. Worthy to note that the 
disease specific mortality among 50+ Hungarian population is 1.8 times higher 
in 2013 compared to 2005 and reached 18,954 inhabitants. Because of the disease 
specific death and direct health care cost an approx. 9.3 billion HUF direct health 
care burden was reported in year 2013 among the 50+ population. ConClusions: 
The health care attendance of pneumonia, meningitis and septicemia diseases 
effects a huge burden on the health care system that grows year by year. By the 
help of a targeted pneumococcal vaccination program a part of the ever growing 
yearly burden could be avoided.
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objeCtives: Malnutrition is a health problem in adulthood period of life. 
Epidemiologic data of malnutrition in adults is limited in Turkey although there 
are several studies focusing on malnutrition in selected populations. This abstract 
aims to report prevalence and incidence of malnutrition in geriatric population in 
Turkey using general health insurance reimbursement database of Social Security 
Institute (SSI). Methods: Since 2011, the Turkish general health insurance sys-
tem has covered 98% of total population of Turkey and the only reimbursement 
authority of general health insurance is SSI. Therefore statistics obtained via the 
SSI database are highly representative of the population of Turkey. From SSI data-
base, person ≥ 65 years of age who received first malnutrition diagnosis between 
1 January 2011 and 31 December 2013 were included to analysis. International 
Classification of Disease (ICD)-10 code E40 to E46 were used to define malnutrition. 
Concomitant diseases to malnutrition were out of abstract scope. Results: Of 
931,079 unique persons at any age had at least one primary malnutrition diagnosis; 
40,109 adults met selection criteria of this abstract. Annual incidence of malnutri-
tion was 0.367%, 0.419% and 0.464% in 2011, 2012 and 2013, respectively (0.123%, 
0.125% and 0.164% in females and 0.145%, 0.150% and 0.196% in males for same 
time periods). Prevalence of malnutrition was 0.254% and 0.341% in 2011-2012 and 
2012-2013 periods, respectively (0.245% and 0.329% in females and 0.266% and 
0.356% in males for same time periods). ConClusions: The study showed the 
prevalence and incidence of malnutrition among geriatric population in Turkey. 
Males are under more risk than females, and both prevalence and incidence of 
malnutrition among geriatric population increase. In conclusion; more efficient 
strategies for diagnosis and treatment of malnutrition in geriatric population of 
Turkey should be developed.
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objeCtives: To assess the prevalence of self-medication and its reason among 
Postgraduate Pharmacy students. Methods: This cross-sectional study was con-
ducted among Postgraduate Pharmacy students of NIPER, Mohali. Study duration 
was six months period of time (Nov. 2014 to Apr. 2015). Participants who were willing 
to participate in the study were included. Participants who had not completed or 
did not return back the questionnaire were excluded. Data collection was based on 
pre-designed questionnaire containing close ended questions. Participants were 
assured of their confidentiality and anonymity. Data collected was analysed using 
€ 750, € 1000 and € 5000 was 0.721, 0.724, 0.730, 0.733, 0.737 and 0.789. ConClusions: 
Based on the evidence presented, SPRM/CDSS is likely to be determined to be cost-
effective in comparison with usual pharmaceutical care.
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objeCtives: Menopausal symptoms associated with reduction in the levels of oestro-
gen can be alleviated through the use of pharmacotherapy. A systematic review and 
meta-analysis were conducted to compare the relative efficacy/safety of conjugated 
oestrogens (CE) 0.45mg/bazedoxifene (BZA) 20mg with other available treatments for 
management of postmenopausal symptoms (PMS). Methods: MEDLINE, EMBASE 
and Cochrane databases were systematically searched (December 2014) to identify 
randomised controlled trials evaluating CE/BZA, tibolone, oestradiol (E2)/(micronised) 
progestin combinations and placebo in this indication. Eligible trials included women 
with an intact uterus and at least 12 months since last menses. Vasomotor symptoms 
(VMS, number of “moderate/severe” hot flushes [HF]) at 4 weeks and the rate of uterine 
bleeding (UB) were analysed via Bayesian network meta-analysis (NMA) with results 
presented as weighted mean difference (WMD) and hazard ratios (HR), respectively, 
along with 95% credible intervals (Crls). A direct pairwise meta-analysis was con-
ducted on the number of “moderate/severe” HF at 12 weeks and severity at 4 and 12 
weeks, expressed as WMD and 95% confidence intervals (CIs). Data were validated by 
Abacus International. Results: Twenty-two studies met the inclusion criteria for the 
meta-analysis. CE/BZA significantly lowered the daily number of “moderate/severe” 
HF compared with placebo at both 4 weeks (WMD:-3.10 [95% CrI:-4.34, -1.88]) and 12 
weeks (WMD:-3.21 [95% CI:-4.30, -2.12; p< 0.05]). The HF severity score was significantly 
lower in patients treated with CE/BZA versus placebo at both 4 weeks (WMD:-0.39 
[95% CI:-0.58, -0.20]; p< 0.05) and 12 weeks (WMD:-0.66 [95% CI:-0.89, -0.44]; p< 0.001). 
The rate of UB with CE/BZA was not significantly different versus placebo (HR: 0.81 
[95% CrI: 0.30, 2.20]) and was significantly less than tibolone 2.5mg (HR: 0.28 [95% CrI: 
0.08, 0.93]). ConClusions: CE/BZA demonstrates a favourable risk-benefit profile 
for management of PMS. CE/BZA treated patients reported a significant improvement 
in VMS with no increased risk of UB versus placebo.
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objeCtives: Students of higher education institutions are prone to practices 
of substance abuse and risky sexual behavior due to individual, peer, social and 
ecological influences. The objective of the current study is to assess practices of 
substance abuse and its relationship with risky sexual behavior among ASTU 
Students. Methods: A total of 447 respondents were selected to fill the question-
ers by using stratified, systematic and random sampling from undergraduate regular 
students while only 426 (95.3%) were completed the questioner correctly and the 
analyses of results were based on 426 respondents. Informal interview with five 
key respondents were also conducted for triangulation of results. The results were 
analyzed by using descriptive statistics such as frequencies and percentage, and 
inferential statistics such as chi-square (x2) and binary logistic regression. Results: 
Prevalence of substance abuse increases with gender differences (X2(6.315) = .012, 
P< .05); previous place of residence (X2(18.327) = .000, P< .05) and school attended 
before joining the university (X2(8.807) = .003, P< .05); while decreases with current 
place of residence (c2(.152) = .696, P> .05). However, sexual behavior of respondents 
decreases with gender difference (X2(.155) = .694, P> .05); previous place of residence 
(X2(.122) = .727, P> .05); school attended before joining the university (X2(.092) = 
.762, P> .05); and current place of residence (X2(.088)= .767, P> .05). ConClusions: 
There is statistical significant relation between substance abuse and gender dif-
ferentials, previous places of residences and school attended before joining the 
university while there is no statistical relation between current places of residences. 
Therefore prevention of practices of substance abuse and risky sexual behaviors 
among students should be strengthened at primary and secondary school program.
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objeCtives: Older patients represent those at greatest risk of adverse drug reac-
tions (ADR) and potentially inappropriate prescribing (PIP). Therefore, they also 
represent the greatest opportunity for pharmacotherapy optimisation. Examining 
prescribing patterns is a key step towards identifying areas in which prescribing 
can be improved. Methods: As part of the SENATOR project, prescribing data was 
collected on 464 older patients presenting at emergency departments with acute 
illness at sites across six EU countries. Patients were followed up at discharge and 
three months post-discharge, where possible. The prescribing data was analysed 
to compare prescribing across the six countries. As the STOPP/START screening 
tool organises criteria by physiological system, the prescribed medicines were 
classified accordingly. Results: In total 8666 medicines were recorded for the 
464 patients. The overall percentages were as follows; cardiovascular indications 
39.01% (n= 3381), central nervous system indications 7.69% (n= 666), endocrine 
disorders 6.91% (n= 599), gastrointestinal indications 9.04% (n= 783), musculo-
skeletal indications 4.3% (n= 373), respiratory tract indications 11.97% (n= 1037), 
urogenital indications 2.05% (n= 178), no valid indication recorded 3.80% (n= 329), 
